MIDLAND, Texas, September 2, 2026, 09:46 CDT — Shares of AST SpaceMobile rallied 9% after analysts set a $92 price target, suggesting a potential $12 billion increase in valuation.
- ASTS rose 8.97% to $60.80 at 10:41:27 EDT.
- Berenberg’s price target of $92 suggests a 51% increase, equating to roughly $12.1 billion in additional equity value.
- On August 31, Director Adriana Cisneros acquired 10,822 shares at a total cost of $619,200.
AST SpaceMobile, Inc. (NASDAQ:ASTS) shares rose 8.97% on Wednesday after Berenberg initiated coverage with a Buy recommendation and set a price target of $92. At 10:41:27 EDT, the stock traded at $60.80.
The target is the bigger signal, suggesting a 51.3% increase from the most recent price. According to Google Finance’s market capitalization, this indicates a projected equity value of about $35.7 billion.
This represents an increase of $12.1 billion over the present $23.6 billion. The premium is higher than AST’s available pro forma cash exceeding $3.7 billion, its $1.30 billion order backlog, and a possible $1 billion in funding from the Japanese government when combined. Although these numbers reflect distinct metrics, in total, they underline the execution assumptions reflected in the target second-quarter filing.
The stock began trading at $58.44 and climbed to $62.88 before easing back from its peak. Volume had reached 7.58 million shares at the latest confirmed quote Google Finance.
ASTS intraday: analyst-driven gap holds
As of
Five-minute closes through 10:40 EDT, followed by the latest quote. Source: Google Finance. USD.
Berenberg described AST as the sole operator to showcase cellular broadband from space using regular phones. The bank referenced over 60 mobile network partners representing around 3 billion subscribers coverage report.
The new target is significantly higher than Wednesday’s price, but still falls short of the upper end of the wider $42.50-to-$108 analyst range set at initiation. The range highlights the extent to which projections vary based on service timing.
Price-to-target bridge
Bar length is scaled to $108, the reported top of the analyst range.
Implied bridge: +51.3% from the latest price, or an estimated $12.1 billion of additional equity value. Wider reported target range: $42.50–$108.
Sources: Berenberg initiation via Investing.com; Google Finance. Equity-value estimate uses the reported market capitalization.
Additional insider buying emerged as a signal. Director Adriana Cisneros purchased 10,822 shares on August 31, spending $619,200. The average price per share was $57.22, according to the September 1 Form 4.
Deployment is still the key factor for valuation. AST stated there are now 13 spacecraft in orbit following six BlueBird launches over a 50-day span. Together, their aperture hardware totaled roughly 20,000 square feet launch report.
Execution ladder behind the valuation
Deployment status and funding markers reported on August 10, 2026.
Source: AST SpaceMobile Q2 2026 business update. Japan funding remains preliminary.
BlueBirds 14, 15, and 16 were slated for shipment soon. Production or assembly was underway for hardware up to BlueBird 46. The company estimated about 45 satellites in orbit by early 2027, according to its presentation.
AST is planning to launch a partner beta service in 2026. The company has deployed 3,000 digital cells throughout the continental United States. Chief Executive Abel Avellan stated, “We are preparing to initiate beta services with select strategic partners.”
Revenue continues to lag behind the valuation. Sales in the second quarter reached $31.5 million. The company maintained its full-year outlook of $150 million to $200 million, driven by government contracts and gateway shipments.
Expenses are rising as well. Adjusted operating costs totalled $119.1 million, increasing from $91.2 million in the previous quarter. Gross capitalized costs for property and equipment stood at roughly $2.3 billion.
Risks: Revenue may be postponed by launch setbacks, regulatory holdups, and delayed partner activation. Liquidity improved with July’s convertible-note financing, though dilution risk increased. Analyst price targets remain widely dispersed.
The upcoming confirmed milestones are the delivery of BlueBirds 14–16 and the initiation of partner beta. For now, the $92 target depends chiefly on how quickly deployments occur rather than on existing revenue. Wednesday’s surge further highlights this difference.
Related articles: NASDAQ:ASTS
